Abstract
Homeobox genes encode transcriptional regulators of embryonic development. Many genetic disorders affecting multiple organ systems have been associated with a diverse array of mutations in one or another of at least 27 different members of this gene family. We briefly describe the affected genes and the major phenotypes presented by the patients that carry the mutations. Although cause-and-effect relationships are difficult to prove in human genetics, there is little doubt that the observed mutations play a crucial role in the etiology of the associated disorders. The impressive wealth of collected data greatly benefits genetic counseling and stimulates efforts to develop novel avenues of targeted therapy
Keywords: Homeobox Genes, Human Genetic Disorders, Bicoid, Dlx3 gene, Emx2 gene, Hox genes, Lim-homeobox gene, Msx genes, Nkx2-5 gene, Paired homeobox genes
Current Molecular Medicine
Title: Homeobox Genes and Human Genetic Disorders
Volume: 2 Issue: 1
Author(s): Yangu Zhao and Heiner Westphal
Affiliation:
Keywords: Homeobox Genes, Human Genetic Disorders, Bicoid, Dlx3 gene, Emx2 gene, Hox genes, Lim-homeobox gene, Msx genes, Nkx2-5 gene, Paired homeobox genes
Abstract: Homeobox genes encode transcriptional regulators of embryonic development. Many genetic disorders affecting multiple organ systems have been associated with a diverse array of mutations in one or another of at least 27 different members of this gene family. We briefly describe the affected genes and the major phenotypes presented by the patients that carry the mutations. Although cause-and-effect relationships are difficult to prove in human genetics, there is little doubt that the observed mutations play a crucial role in the etiology of the associated disorders. The impressive wealth of collected data greatly benefits genetic counseling and stimulates efforts to develop novel avenues of targeted therapy
Export Options
About this article
Cite this article as:
Zhao Yangu and Westphal Heiner, Homeobox Genes and Human Genetic Disorders, Current Molecular Medicine 2002; 2 (1) . https://dx.doi.org/10.2174/1566524023363077
DOI https://dx.doi.org/10.2174/1566524023363077 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Identification of Molecular Targets Associated with Ethanol Toxicity and Implications in Drug Development
Current Pharmaceutical Design Mental Health Disorder Therapeutic Modalities Modified for the GMS
Current Psychiatry Reviews PCSK9 Inhibition - A Novel Mechanism to Treat Lipid Disorders?
Current Pharmaceutical Design Nutraceuticals and Diet-based Phytochemicals in Type 2 Diabetes Mellitus: From Whole Food to Components with Defined Roles and Mechanisms
Current Diabetes Reviews Drug Interactions During Periodontal Therapy in HIV-Infected Subjects
Mini-Reviews in Medicinal Chemistry Abdominal Aortic Calcification: Clinical Significance, Mechanisms and Therapies
Current Pharmaceutical Design Prognostic Role of Sub-Clinical Hypothyroidism in Chronic Heart Failure Outpatients
Current Pharmaceutical Design Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer’s Disease and Less Well-Known Diseases
Current Medicinal Chemistry Evidence-Based Percutaneous Closure of the Left Atrial Appendage in Patients with Atrial Fibrillation
Current Cardiology Reviews PUFA for Human Health: Diet or Supplementation?
Current Pharmaceutical Design Novel Molecules Targeting Dyslipidemia and Atherosclerosis
Current Medicinal Chemistry ATP-Binding Cassette Transporters A1 and G1, HDL Metabolism, Cholesterol Efflux, and Inflammation: Important Targets for the Treatment of Atherosclerosis
Current Drug Targets Editorial: Inflammation and Heart Diseases
Current Pharmaceutical Design Circulating Levels of Uric Acid and Risk for Metabolic Syndrome
Current Diabetes Reviews MicroRNAs in Breast Cancer: One More Turn in Regulation
Current Drug Targets Inflammatory Markers in Hyperlipidemia: From Experimental Models to Clinical Practice
Current Pharmaceutical Design Vasopressin Receptor Antagonists in Heart Failure
Recent Patents on Cardiovascular Drug Discovery Bioactive Proteins and Peptides from Soybeans
Recent Patents on Food, Nutrition & Agriculture Omega-3 Fatty Acids Supplementation in Psychiatric Disorders: A Systematic Review
Current Psychopharmacology Protein Tyrosine Phosphatase 1B Inhibition: Opportunities and Challenges
Current Medicinal Chemistry